One Capital Management LLC Sells 10,232 Shares of Koninklijke Philips (NYSE:PHG)

One Capital Management LLC reduced its holdings in Koninklijke Philips (NYSE:PHG) by 3.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 270,137 shares of the technology company’s stock after selling 10,232 shares during the period. One Capital Management LLC’s holdings in Koninklijke Philips were worth $6,840,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Wilmington Savings Fund Society FSB acquired a new stake in Koninklijke Philips in the 3rd quarter valued at $54,000. Whipplewood Advisors LLC acquired a new stake in Koninklijke Philips in the 4th quarter valued at $55,000. Allworth Financial LP increased its stake in Koninklijke Philips by 24.9% in the 4th quarter. Allworth Financial LP now owns 3,993 shares of the technology company’s stock valued at $105,000 after buying an additional 797 shares during the last quarter. RPg Family Wealth Advisory LLC acquired a new stake in Koninklijke Philips in the 3rd quarter valued at $107,000. Finally, Smartleaf Asset Management LLC increased its stake in Koninklijke Philips by 177.4% in the 4th quarter. Smartleaf Asset Management LLC now owns 4,489 shares of the technology company’s stock valued at $114,000 after buying an additional 2,871 shares during the last quarter. 13.67% of the stock is currently owned by institutional investors and hedge funds.

Koninklijke Philips Stock Up 2.3 %

Shares of PHG opened at $27.16 on Thursday. Koninklijke Philips has a 52 week low of $19.10 and a 52 week high of $32.91. The firm has a market cap of $25.52 billion, a P/E ratio of -32.33, a price-to-earnings-growth ratio of 0.82 and a beta of 0.77. The firm’s 50-day simple moving average is $26.44 and its 200 day simple moving average is $28.01. The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.74 and a current ratio of 1.23.

Koninklijke Philips (NYSE:PHG) last announced its quarterly earnings results on Wednesday, February 19th. The technology company reported $0.54 EPS for the quarter, missing analysts’ consensus estimates of $0.55 by ($0.01). Koninklijke Philips had a negative net margin of 3.88% and a positive return on equity of 10.85%. The company had revenue of $5.38 billion during the quarter, compared to analyst estimates of $5.10 billion. On average, analysts forecast that Koninklijke Philips will post 1.63 earnings per share for the current year.

Koninklijke Philips Cuts Dividend

The company also recently declared an annual dividend, which will be paid on Friday, June 6th. Stockholders of record on Tuesday, May 13th will be issued a dividend of $0.886 per share. This represents a dividend yield of 2.9%. The ex-dividend date is Tuesday, May 13th. Koninklijke Philips’s dividend payout ratio (DPR) is presently -89.29%.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on PHG. UBS Group upgraded shares of Koninklijke Philips from a “neutral” rating to a “buy” rating in a research note on Thursday, February 20th. BNP Paribas upgraded shares of Koninklijke Philips from a “neutral” rating to an “outperform” rating in a research note on Tuesday, February 25th. Finally, StockNews.com lowered shares of Koninklijke Philips from a “buy” rating to a “hold” rating in a research note on Friday, February 28th. Three analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy”.

Koninklijke Philips Company Profile

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.